IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to boost platelets in chronic blood disorder
Disease control CompletedThis study tested whether a drug called avatrombopag is safe and effective at raising platelet counts in Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. Participants took the drug for 26 weeks, and researchers mea…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
New pill tested to help patients with low platelets avoid dangerous bleeding
Disease control CompletedThis study tested a daily pill called lusutrombopag in Chinese adults with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. The goal was to see if the drug could safely raise and maintain platele…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with rare bleeding disorder
Disease control CompletedThis study tested whether a medicine called avatrombopag could safely and effectively raise platelet counts in children with long-term immune thrombocytopenia (ITP), a condition that causes low platelets and increased bleeding risk. 75 children participated, receiving either the …
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill shows promise for stubborn blood disorder
Disease control CompletedThis study tested a new oral medication called PRN1008 (rilzabrutinib) for adults with immune thrombocytopenia (ITP), a condition causing dangerously low platelet counts. It involved about 86 people whose previous treatments had stopped working or didn't help enough. The main goa…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Researchers dig into why cancer can trigger a dangerous blood disorder
Knowledge-focused CompletedThis study aimed to understand why some people with cancer also develop a condition called immune thrombocytopenia (ITP), which causes dangerously low platelet counts and bleeding risk. Researchers looked back at the medical records of 33 adult patients who had both ITP and cance…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Doctors track rare blood disorders to find better treatment paths
Knowledge-focused CompletedThis study created a registry to track children and young adults with severe immune cytopenias—rare conditions where the immune system attacks blood cells. Researchers observed 80 participants over four years to better understand these diseases, improve diagnosis, and document ho…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC